EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Diagnosis of Pemphigoid and Pemphigus: A Comparative Study

Yan Wang iD, Zhe Fan iD, Jie Zhang iD, Min Bai, Jin-Li Qin, Chao-Jun Hu, Ya-Gang Zuo iD

International Journal of Molecular Sciences · 14.07.2026 · 27 (14) · 6272

DOI: 10.3390/ijms27146272 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2026. Verfasst von Yan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Complex Severe and Rare Diseases, Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medica…. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Pemphigus, Luminescent Measurements. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National High Level Hospital Clinical Research Funding, National Key Clinical Specialty Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune bullous diseases (AIBDs), including pemphigus vulgaris (PV), pemphigus foliaceus (PF), and bullous pemphigoid (BP), are mediated by autoantibodies against desmogleins (DSG1, DSG3) or hemidesmosomal proteins (BP180, BP230). While enzyme-linked immunosorbent assay (ELISA) is commonly applied for antibody detection, chemiluminescent immunoassay (CLIA) offers advantages such as a broader dynamic range and higher automation. To compare the diagnostic performance of CLIA and ELISA for detecting autoantibodies in patients with AIBDs, we collected 255 serum samples (92 controls, 84 BP, 69 PV, 10 PF) and 85 blister fluid samples (42 controls, 43 BP). Serum was tested for anti-BP180, anti-BP230, anti-DSG1, and anti-DSG3 antibodies using both assays; blister fluid was tested for anti-BP180 and anti-BP230. Using established cut-offs, the assays demonstrated good diagnostic accuracy for anti-BP180, anti-DSG1, and anti-DSG3 in serum, and excellent concordance (>90%). Receiver operating characteristic analysis revealed acceptable to excellent diagnostic value for both sample types, with CLIA generally achieving a higher area under the curve. Spearman’s correlation and linear regression analyses confirmed moderate to strong agreement between the two methods. In conclusion, CLIA showed strong concordance with and comparable diagnostic accuracy to ELISA for AIBD serodiagnosis. Furthermore, this is the first study to evaluate CLIA for autoantibody detection in blister fluid from BP patients, demonstrating that blister fluid may serve as a less invasive sample type for diagnosis. Our cut-off analysis in a treated cohort also suggested that manufacturer-recommended thresholds may yield false-negative results, highlighting the need for population-specific reference intervals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousPemphigusLuminescent MeasurementsHumansEnzyme-Linked Immunosorbent AssayAutoantibodiesFemaleImmunoassayMaleSensitivity and SpecificityAutoantigensROC CurveCollagen Type XVIIMiddle AgedDesmoglein 3AgedDesmoglein 1Non-Fibrillar Collagens

Stichwörter der Autor:innen

autoantibodybullous pemphigoidchemiluminescence immunoassayenzyme-linked immunosorbent assaypemphigus

Substanzen

AutoantibodiesAutoantigensCollagen Type XVIIDesmoglein 3Desmoglein 1Non-Fibrillar Collagens

Autor:innen und Institutionen

  • State Key Laboratory of Complex Severe and Rare Diseases, Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Yan Wang, Zhe Fan, Jie Zhang, Ya-Gang Zuo

Förderung

  • Beijing Municipal Natural Science Foundation
  • National High Level Hospital Clinical Research Funding
  • National Key Clinical Specialty Project of China

Zitieren

APA

Wang, Y., Fan, Z., Zhang, J., Bai, M., Qin, J. L., Hu, C. J., & Zuo, Y. G. (2026). Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Diagnosis of Pemphigoid and Pemphigus: A Comparative Study. International Journal of Molecular Sciences, 27(14), 6272. https://doi.org/10.3390/ijms27146272

Vancouver

Wang Y, Fan Z, Zhang J, Bai M, Qin JL, Hu CJ, et al. Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Diagnosis of Pemphigoid and Pemphigus: A Comparative Study. International Journal of Molecular Sciences. 2026;27(14):6272. doi:10.3390/ijms27146272

BibTeX
@article{Wang2026,
  author = {Wang, Yan and Fan, Zhe and Zhang, Jie and Bai, Min and Qin, Jin-Li and Hu, Chao-Jun and Zuo, Ya-Gang},
  title = {Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Diagnosis of Pemphigoid and Pemphigus: A Comparative Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6272},
  doi = {10.3390/ijms27146272}
}
Kostenlos starten →